Flat pricing at every dose

Tirzepatide starts at 2.5 mg and climbs to 10 or 15 mg. On many programmes the price climbs with it, so your bill rises exactly as the treatment starts working.

Flat pricing removes that, and it removes something subtler too: the quiet financial pressure to push on to the next dose rather than hold steady for a month while side effects settle. That should be a clinical decision, and flat pricing keeps it one.

How we decided what belongs here

• Provider states the price is the same at every prescribed dose.
• We only list providers where we could verify that claim — an unverified provider is absent, not disqualified.
• Sorted cheapest first.

6 of the 23 providers we track qualify. Prices checked 2026-09-18 and re-checked periodically.

Questions people ask us

How much can dose-based pricing add?

It varies, but on programmes that tier by dose the difference between a starter and maintenance dose can be $100 a month or more — well over a thousand dollars a year.

Can I stay on a lower dose?

Often yes, and plenty of people settle at a middle dose. On a flat-rate programme that costs you nothing, which is the point of this page.

Before you choose on price

Worth knowing before you start: the approved oral options avoid injections entirely and start around $149, and if you are on Medicare the $50 programme begins in July 2026.

In SURMOUNT-1, adults with obesity lost an average of 19.5% of body weight on 10 mg and 20.9% on 15 mg over 72 weeks. That figure comes from a controlled trial of the active ingredient, not from any particular seller's product.